Literature DB >> 15784601

Antibody against the carboxyl terminus of intimin alpha reduces enteropathogenic Escherichia coli adherence to tissue culture cells and subsequent induction of actin polymerization.

Humberto M Carvalho1, Louise D Teel, John F Kokai-Kun, Alison D O'Brien.   

Abstract

The C-terminal third of intimin binds to its translocated receptor (Tir) to promote attaching and effacing lesion formation during infection with enteropathogenic Escherichia coli (EPEC). We observed that the adherence of EPEC strains to HEp-2 cells was reduced and that actin polymerization was blocked by antibody raised against the C-terminal third of intimin alpha.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15784601      PMCID： PMC1087450          DOI： 10.1128/IAI.73.4.2541-2546.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  22 in total

1.  New flow cytometric method to quantify the inhibition of enteropathogenic Escherichia coli adhesion by anti-adhesin antibodies.

Authors:  Séverine Boullier; Christian Tasca; Alain Milon
Journal:  Cytometry A       Date:  2003-06       Impact factor: 4.355

2.  Infectious infantile enteritis, yesterday and today.

Authors:  J Taylor
Journal:  Proc R Soc Med       Date:  1970-12

3.  Decreased adherence of enterohemorrhagic Escherichia coli to HEp-2 cells in the presence of antibodies that recognize the C-terminal region of intimin.

Authors:  L J Gansheroff; M R Wachtel; A D O'Brien
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

Review 4.  Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.

Authors:  P M Griffin; S M Ostroff; R V Tauxe; K D Greene; J G Wells; J H Lewis; P A Blake
Journal:  Ann Intern Med       Date:  1988-11-01       Impact factor: 25.391

5.  A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.

Authors:  A E Jerse; J Yu; B D Tall; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 6.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

7.  The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor.

Authors:  M M Levine; J P Nataro; H Karch; M M Baldini; J B Kaper; R E Black; M L Clements; A D O'Brien
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

8.  Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket.

Authors:  Hui Liu; Padhma Radhakrishnan; Loranne Magoun; Moses Prabu; Kenneth G Campellone; Pamela Savage; Feng He; Celia A Schiffer; John M Leong
Journal:  Mol Microbiol       Date:  2002-09       Impact factor: 3.501

9.  Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  S Knutton; T Baldwin; P H Williams; A S McNeish
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.

Authors:  H W Moon; S C Whipp; R A Argenzio; M M Levine; R A Giannella
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441
View more
  8 in total

1.  Dissection of the role of pili and type 2 and 3 secretion systems in adherence and biofilm formation of an atypical enteropathogenic Escherichia coli strain.

Authors:  Rodrigo T Hernandes; Miguel A De la Cruz; Denise Yamamoto; Jorge A Girón; Tânia A T Gomes
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

2.  Fimbrial adhesins produced by atypical enteropathogenic Escherichia coli strains.

Authors:  Rodrigo T Hernandes; Irina Velsko; Suely C F Sampaio; Waldir P Elias; Roy M Robins-Browne; Tânia A T Gomes; Jorge A Girón
Journal:  Appl Environ Microbiol       Date:  2011-09-16       Impact factor: 4.792

3.  THE ROLE OF SPECIFIC IgG AND COMPLEMENT IN COMBATING A PRIMARY MUCOSAL INFECTION OF THE GUT EPITHELIUM.

Authors:  C Belzer; Q Liu; M C Carroll; L Bry
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23

4.  Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157:H7 or O26:H-.

Authors:  P M van Diemen; F Dziva; A Abu-Median; T S Wallis; H van den Bosch; G Dougan; N Chanter; G Frankel; M P Stevens
Journal:  Vet Immunol Immunopathol       Date:  2007-01-09       Impact factor: 2.046

5.  Immune Response in Calves Vaccinated with Type Three Secretion System Antigens and Shiga Toxin 2B Subunit of Escherichia coli O157:H7.

Authors:  Luisina Martorelli; Sergio Garbaccio; Daniel A Vilte; Adriana A Albanese; María P Mejías; Marina S Palermo; Elsa C Mercado; Cristina E Ibarra; Angel A Cataldi
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

6.  Efficient induction of comprehensive immune responses to control pathogenic E. coli by clay nano-adjuvant with the moderate size and surface charge.

Authors:  Weiyu Chen; Huali Zuo; Timothy J Mahony; Bing Zhang; Barbara Rolfe; Zhi Ping Xu
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

7.  The malate synthase of Paracoccidioides brasiliensis is a linked surface protein that behaves as an anchorless adhesin.

Authors:  Benedito Rodrigues da Silva Neto; Julhiany de Fátima da Silva; Maria José Soares Mendes-Giannini; Henrique Leonel Lenzi; Célia Maria de Almeida Soares; Maristela Pereira
Journal:  BMC Microbiol       Date:  2009-12-24       Impact factor: 3.605

8.  Immunogenic evaluation of chimeric recombinant protein against ETEC, EHEC and Shigella.

Authors:  Farzane Khalouie; Seyed Latif Mousavi; Shahram Nazarian; Jafar Amani; Poune Pourfarzam
Journal:  Mol Biol Res Commun       Date:  2017-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.